Detection of AAV-2 in Cervical Cancer
Author Information
Author(s): Zheng B Y, Li X D, Wiklund F, Chowdhry S, Ångstrom T, Hallmans G, Dillner J, Wallin K L
Primary Institution: Karolinska Institute
Hypothesis
Is AAV-2 infection associated with the risk of developing cervical cancer?
Conclusion
AAV-2 DNA was found in a low proportion of cervical cancer cases, and there was no evidence that AAV infection reduces the risk of cervical cancer.
Supporting Evidence
- 2% of prediagnostic smears from cancer cases were positive for AAV-2.
- 12% of cervical cancer biopsies were positive for AAV-2 at diagnosis.
- 3% of matched control smears were positive for AAV-2.
Takeaway
The study looked at whether a virus called AAV-2 could help prevent cervical cancer, but it found that having this virus didn't really change the chances of getting cancer.
Methodology
A nested case-control study was performed with 104 women who developed cervical cancer and 104 matched controls, testing for AAV and HPV using PCR.
Potential Biases
There may be selection bias due to the retrospective nature of the study.
Limitations
The study relied on archival samples, which may have degraded DNA, and the low prevalence of AAV-2 could affect the results.
Participant Demographics
Women aged 25-59 from Västerbotten county, Sweden.
Statistical Information
P-Value
4.39
Confidence Interval
1.11–20.29
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website